Purchase Order 75N91023P00861
Award Date 9/15/23
Potential Completion Date 9/14/24
Potential Value $121K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Potomac, MD 20878, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price contract for $803,500.00 was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Vector Biomed Inc. for the production and stability testing of clinical grade lentiviral vector. The services include manufacturing a minimum of 50mg of GMP/clinical grade transfer plasmid and 400ml of concentrated, GMP grade lentiviral vector, as well as performing stability testing...
- This firm-fixed price purchase order contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Expression Manufacturing LLC, a for-profit limited liability company, to provide 250 ml of concentrated lentiviral vector and conduct stability testing. The contract, valued at $648,968.00, has an ultimate completion date of August 31, 2029. This sole-source procurement was originally...
- This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Vector Biomed Inc. for the production of a lentiviral vector. The contract has a ceiling value of $653,000.00 and a period of performance ending on September 23, 2026. Vector Biomed Inc. is a for-profit manufacturer of advanced biological research materials, specializing in the production of lentiviral vectors to support medical...
- This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Vector Biosystems, Inc. (doing business as Vector Biolabs), a for-profit biotechnology company that provides gene delivery products and services. The $16,120 contract is for the delivery of an AAV viral vector with an EF1a promotor expressing a green fluorescent protein. This contract supports NCATS' biomedical...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) to Lentigen Technology, Inc., a for-profit organization, for the manufacture of a Good Manufacturing Practice (GMP) lot of a lentiviral vector encoding a chimeric antigen receptor (CAR) targeting CD22. The contract, valued at $205,000.00, is for the production of this vector to support an ongoing clinical trial...
- The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded a $16,999 firm fixed-price purchase order to Vectorbuilder Inc., a specialized biotechnology company, for large-scale 15 and ultra-purification packaging service for PAAV240227-1016XNQ. The contract, which does not utilize any set-aside designations, has a completion date of September 3, 2025. Vectorbuilder, a global leader in gene delivery...
- This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Lentigen Technology, Inc. for the manufacture of a good manufacturing practice (GMP) lot of a lentiviral vector encoding a CD19/CD22 targeting bispecific chimeric antigen receptor (CD19/CD22 BiCAR) gene for clinical use. The contract has a ceiling value of $322,000.00 and a completion date of August 7, 2017. The contract was awarded on August 8, 2016 and was not set aside...
- This federal contract award, valued at $10,600.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The contract was awarded to Vector Biosystems, Inc., doing business as Vector Biolabs, a minority-owned, small disadvantaged biotechnology company that provides gene delivery products and services. The contract is for the delivery of an AAV8-SPC512-MCHERRY construct, which is likely a gene...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $664,000.65 firm fixed price purchase order to Vigene Biosciences, Inc., a minority-owned small business, for the delivery of clinical grade virus vectors. The award was made through a sole source acquisition process under Federal Acquisition Regulation (FAR) Part 12 for commercial items. The vectors are needed to support ongoing research at NIAID's Laboratory...
- The National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, awarded a $15,238 firm fixed price purchase order to Vectorbuilder Inc. for AAV8 large-scale 10 and ultra-purification packaging services. The contract has an ultimate completion date of August 26, 2025. Vectorbuilder is a specialized biotechnology company that provides gene delivery and molecular biology services to various federal agencies, including the Department of Veterans Affairs...